Oscar Health, Inc.

NYSE:OSCR

Medical - Healthcare Plans

Healthcare
$27.57 +0.18%

+$0.05 today

Market cap
$7.15B
Beta
2.39
P/E (TTM)
-214.2
EPS (TTM)
-$0.13
52W Low $10.69High $29.81

Volume 7.38M

Average 7.51M

OSCR Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Oscar Health, Inc.NYSE: OSCR

Accounts Payables · Q2 FY2026 · quarter ended Jun 2026

Accounts payables turns positive

Q2 FY2026 accounts payables was $18.88M, compared with -$68.28M a year earlier. Trailing-twelve-month accounts payables was $74.49M. Over 3 fiscal years it compounded at -15.7% a year.

Context

  • Accounts payables amounted to 1.4% of revenue in FY2025, unchanged from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly accounts payables holds near $18.88M or moves back toward the trailing-twelve-month quarterly average of $18.62M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$18.88M+1131.2% QoQ
Last fiscal yearDec 2025
$167.72M+26.0% YoY
LTMJun 2026
$74.49M-60.0% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+127.6%——
1 year+26.0%——
3-year CAGR-15.7%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
167.72M USD
Year-over-year change
+26.0%

Accounts Payables vs competitors

How OSCR compares with its peers on the latest reported figures

  • OSCR's LTM Jun 2026 accounts payables of $74.49M is the 5th largest of the 8 companies compared; the peer median is $62M.
  • Its year-over-year change of -60.0% is the 6th highest of 8, against a peer median of +122.4%.
  • Accounts payables amounts to 0.5% of revenue for OSCR, versus a peer median of 0.2%.
OSCR Competitors Peer median
Accounts Payables for OSCR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CNCCentene CorporationLTM Jun 2026$6.37B +332.8%—3.3%
CICigna CorporationLTM Sep 2026$3.55B +304.3%+17.3%1.2%
ELVElevance Health Inc.LTM Sep 2026$1.02B -400.6%—0.5%
CVSCVS Health CorporationLTM Jun 2026$947M -80.8%-3.3%0.2%
OSCROscar Health, Inc.LTM Jun 2026$74.49M -60.0%-15.7%0.5%
MOHMolina Healthcare, Inc.LTM Sep 2026$62M +231.9%—0.1%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$6.26M +69.2%—0.1%
CLOVClover Health Investments, Corp.LTM Jun 2026$1.46M +122.4%-40.0%0.1%
Peer median (excluding OSCR) $62M+122.4%-3.3%0.2%

Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(571.43M)(609.55M)(270.59M)26.12M(442.9M)
Depreciation & Amortization14.61M15.28M30.69M32.15M28.89M
Deferred Income Tax(101K)(165K)58K(2.34M)2.45M
Stock-Based Compensation86.3M112.33M159.68M109.82M87.65M
Change in Working Capital247.7M855M(192.09M)838.86M1.46B
Accounts Receivables80.45M(551.15M)636.23M(177.52M)98.57M
Inventory00000
Accounts Payables(39.46M)280.23M(395.81M)133.09M167.72M
Other Working Capital206.71M1.13B(432.51M)883.29M1.19B
Other Non-Cash Items41.19M7.46M86K(26.42M)(40.24M)
Operating Cash Flow(181.75M)380.35M(272.16M)978.19M1.09B
Capital Expenditures(25.89M)(29.01M)(25.58M)(27.9M)(36.37M)
Acquisitions (Net)7.23M0000
Purchases of Investments(1.81B)(1.19B)(836.98M)(2.13B)(1.01B)
Sales of Investments1.05B994.08M1.44B770.04M804.96M
Other Investing Activities(555K)1.12M(2.28M)3.93M4.28M
Investing Cash Flow(774.52M)(226.52M)577.19M(1.39B)(241.06M)
Debt Repayment(153.17M)305M00348.21M
Common Stock Issued1.35B1.3M3.96M68.39M55.03M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities43.56M(5.19M)2.49M0(4.04M)
Financing Cash Flow1.24B301.11M6.45M68.39M399.21M
Effect of Forex Changes00000
Net Change in Cash282.45M454.94M311.47M(340.85M)1.25B
Free Cash Flow(207.63M)351.34M(297.74M)950.3M1.06B

Oscar Health, Inc.

NYSE:OSCR

Intrinsic Alpha fair value

Locked

Current Price

$27.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.